OIM
YTEN

Oracle Investment Management’s Yield10 Bioscience, Inc. Common Stock YTEN Stock Holding History

Oracle Investment Management’s Portfolio YTEN Stock Details YTEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-76
Closed -$1.38M – 20
2016
Q1 		$1.38M Sell
76
-21
-22% -$311K 0.36% 18
2015
Q4 		$1.44M Sell
97
-3
-3% -$60.5K 0.25% 21
2015
Q3 		$1.32M Sell
100
-20
-17% -$513K 0.27% 22
2015
Q2 		$4.33M Sell
120
-6
-5% -$247K 0.52% 23
2015
Q1 		$4.5M Sell
126
-13
-9% -$416K 0.57% 22
2014
Q4 		$3.28M Buy
139
+48
+53% +$1.65M 0.43% 25
2014
Q3 		$4.76M Buy
91
+62
+214% +$2.68M 0.66% 21
2014
Q2 		$1.44M Hold
29
– – 0.18% 27
2014
Q1 		$2.16M Hold
29
– – 0.25% 27
2013
Q4 		$2.09M Hold
29
– – 0.29% 23
2013
Q3 		$2.09M Hold
29
– – 0.3% 21
2013
Q2 		$2.35M Buy
+29
New +$2.8M 0.41% 22

Other funds holding YTEN

BC
Birchview Capital Burlington, Vermont $176M AUM 95.04% 1-Year Est. Return
CC
Cannell & Co New York $3.15B AUM 30.62% 1-Year Est. Return
GC
GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FA
FCG Advisors Chatham, New Jersey $425M AUM 12.09% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
MCM
McRae Capital Management Morristown, New Jersey $508M AUM 14.21% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Oracle Investment Management's YTEN Position: Q2 2016 in Review

Oracle Investment Management sold out of Yield10 Bioscience, Inc. Common Stock (YTEN) in Q2 2016, closing a stake of 76 shares — an estimated $1.38M sold.

Oracle Investment Management first reported a position in YTEN in Q2 2013 and held it in 12 quarters. The position peaked at $4.76M in Q3 2014. 8 funds tracked by Wall St. Rank hold YTEN as of Q2 2016.

  • Oracle Investment Management reported no remaining Yield10 Bioscience, Inc. Common Stock position as of Q2 2016 after selling out during the quarter.
  • Oracle Investment Management sold 76 Yield10 Bioscience, Inc. Common Stock shares in Q2 2016, an estimated $1.38M.
  • Oracle Investment Management first reported a position in Yield10 Bioscience, Inc. Common Stock in Q2 2013 and held it in 12 quarters.
  • Oracle Investment Management's Yield10 Bioscience, Inc. Common Stock position peaked at $4.76M in Q3 2014.
  • 8 funds tracked by Wall St. Rank held Yield10 Bioscience, Inc. Common Stock as of Q2 2016.

Based on Oracle Investment Management's 13F filing for Q2 2016, filed 15 Aug 2016.